• PrEP and PEP, including an overview of current clinical data, pharmacological considerations, and implementation in key populations.
  • Vaccine research, including an update on the clinical trials and insights into the vaccine landscape and prospects of monoclonal antibodies for HIV prevention.
  • Behavioral aspects and interventions, with discussions about regimen adherence, community-based actions, peer-supported interventions, as well as the interplay between PrEP, PEP, and high-risk behavior.

Daugiau informacijos čia